nach oben

Inflammopharmacology

Erschienen in:

01.04.2013 | Review

Lyme disease: aetiopathogenesis, factors for disease development and control

verfasst von: I. R. Kean, K. L. Irvine

Erschienen in: Inflammopharmacology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Lyme disease is caused by infection with several genospecies from the Borrelia burgdorferi sensu lato (s.l.) complex, and is transmitted by ixodid ticks. Human disease is an infrequent sequel to infection, which suggests that multiple factors underlie disease development. Several innate immune defects modulating disease development are observed in both natural and experimental infections, and significant heterogeneity exists between B. burgdorferi s.l. spirochaetes. These factors create a panel of presentations from asymptomatic carriage to overt and variable disease. In this short review we summarise the host immune responses associated with Lyme disease in humans, domestic species and laboratory mouse strains, and discuss B. burgdorferi s.l. pathogenicity. We also describe briefly the epidemiology of Lyme disease, and current options for the treatment and prevention.

Aberer E (2007) Lyme borreliosis—an update. J. Dtsch. Dermatol. Ges. 5:406–414PubMedCrossRef

Alexopoulou L, Thomas V, Schnare M, Lobet Y, Anguita J, Schoen R, Medzhitov R, Fikrig E, Flavell R (2002) Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat Med 8:878–884PubMed

Antonara S, Chafel R, LaFrance M, Coburn J (2007) Borrelia burgdorferi adhesins identified using in vivo phage display. Mol Microbiol 66:262–276PubMedCrossRef

Barthold S (1991) Infectivity of Borrelia burgdorferi relative to route of inoculation and genotype in laboratory mice. J Infect Dis 163:419–420PubMedCrossRef

Benach JL, Coleman JL, Skinner RA, Bosler EM (1987) Adult Ixodes dammini on rabbits: a hypothesis for the development and transmission of Borrelia burgdorferi. J Infect Dis 155:1300–1306PubMedCrossRef

Benoist C, Mathis D (2001) Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2:797–801PubMedCrossRef

Bernardino A, Myers T, Alvarez X, Hasegawa A, Philipp M (2008) Toll-like receptors: insights into their possible role in the pathogenesis of lyme neuroborreliosis. Infect Immun 76:4385–4395PubMedCrossRef

Blander J, Medzhitov R (2006) On regulation of phagosome maturation and antigen presentation. Nat Immunol 7:1029–1035PubMedCrossRef

Blevins J, Hagman K, Norgard M (2008) Assessment of decorin-binding protein A to the infectivity of Borrelia burgdorferi in the murine models of needle and tick infection. BMC Microbiol 8:82PubMedCrossRef

Brooks C, Hefty P, Jolliff S, Akins D (2003) Global analysis of Borrelia burgdorferi genes regulated by mammalian host-specific signals. Infect Immun 71:3371–3383PubMedCrossRef

Brown E, Wooten R, Johnson B, Iozzo R, Smith A, Dolan M, Guo B, Weis J, Hook M (2001) Resistance to Lyme disease in decorin-deficient mice. J. Clin. Invest 107:845–852PubMedCrossRef

Burgdorfer W, Barbour A, Hayes S, Benach J, Grunwaldt E, Davis J (1982) Lyme disease-a tick-borne spirochetosis? Science 216:1317–1319PubMedCrossRef

Caimano M, Eggers C, Gonzalez C, Radolf J (2005) Alternate sigma factor RpoS is required for the in vivo-specific repression of Borrelia burgdorferi plasmid lp54-borne ospA and lp6.6 genes. J Bacteriol 187:7845–7852PubMedCrossRef

Carroll J, Garon C, Schwan T (1999) Effects of environmental pH on membrane proteins in Borrelia burgdorferi. Infect Immun 67:3181–3187PubMed

Casjens S, Palmer N, van Vugt R, Huang W, Stevenson B, Rosa P, Lathigra R, Sutton G, Peterson J, Dodson R, Haft D, Hickey E, Gwinn M, White O, Fraser C (2000) A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 35:490–516PubMedCrossRef

Casjens S, Mongodin E, Qiu W, Luft B, Schutzer S, Gilcrease E, Huang W, Vujadinovic M, Aron J, Vargas L, Freeman S, Radune D, Weidman J, Dimitrov G, Khouri H, Sosa J, Halpin R, Dunn J, Fraser C (2012) Genome stability of Lyme disease spirochetes: comparative genomics of Borrelia burgdorferi plasmids. PLoS ONE 7:e33280PubMedCrossRef

Chang Y, Ku Y, Chang C, Chang C, McDonough S, Divers T, Pough M, Torres A (2005) Antibiotic treatment of experimentally Borrelia burgdorferi-infected ponies. Vet Microbiol 107:285–294PubMedCrossRef

Coleman A, Yang X, Kumar M, Zhang X, Promnares K, Shroder D, Kenedy M, Anderson J, Akins D, Pal U (2008) Borrelia burgdorferi complement regulator-acquiring surface protein 2 does not contribute to complement resistance or host infectivity. PLoS ONE 3:3010ePubMedCrossRef

Doria A, Canova M, Tonon M, Zen M, Rampudda E, Bassi N, Atzeni F, Zampieri S, Ghirardello A (2008) Infections as triggers and complications of systemic lupus erythematosus. Autoimmune Rev 8:24–28CrossRef

Dudai Y, Buxbaum J, Corfas G, Ofarim M (1987) Formamidines interact with Drosophila octopamine receptors, alter the flies’ behaviour and reduce their learning ability. J Comp Physiol 161:739–746CrossRef

Ekerfelt C, Jarefors S, Tynngard N, Hedlund M, Sander B, Bergstrom S, Forsberg P, Ernerudh J (2003) Phenotypes indicating cytolytic properties of Borrelia-specific interferon-gamma secreting cells in chronic Lyme neuroborreliosis. J Neuroimmunol 145:115–126PubMedCrossRef

Faulde M, Albiez G, Nehring O (2010) Insecticidal, acaricidal and repellent effects of DEET- and IR3535-impregnated bed nets using a novel long-lasting polymer-coating technique. Parasitol Res 106:957–965PubMedCrossRef

Fischer J, Parveen N, Magoun L, Leong J (2003) Decorin-binding proteins A and B confer distinct mammalian cell type-specific attachment by Borrelia burgdorferi, the Lyme disease spirochete. Proc Natl Acad Sci USA 100:7307–7312 (Epub 2003 May 28)PubMedCrossRef

Fraser C, Casjens S, Huang W, Sutton G, Clayton R, Lathigra R, White O, Ketchum K, Dodson R, Hickey E, Gwinn M, Dougherty B, Tomb J, Fleischmann R, Richardson D, Peterson J, Kerlavage A, Quackenbush J, Salzberg S, Hanson M, van Vugt R, Palmer N, Adams M, Gocayne J, Weidman J, Utterback T, Watthey L, McDonald L, Artiach P, Bowman C, Garland S, Fuji C, Cotton M, Horst K, Roberts K, Hatch B, Smith H, Venter J (1997) Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580–586PubMedCrossRef

Gammons M, Salam G (2002) Tick removal. Am Fam Physician 66:643–645PubMed

Gautam A, Dixit S, Philipp M, Singh S, Morici L, Kaushal D, Dennis V (2011) Interleukin-10 alters effector functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammation. Infect Immun 79:4876–4892PubMedCrossRef

Hancock P, Brackley R, Palmer S (2011) Modelling the effect of temperature variation on the seasonal dynamics of Ixodes ricinus tick populations. Int J Parasitol 41:513–522PubMedCrossRef

Hartmann K, Corvey C, Skerka C, Kirschfink M, Karas M, Brade V, Miller J, Stevenson B, Wallich R, Zipfel P, Kraiczy P (2006) Functional characterization of BbCRASP-2, a distinct outer membrane protein of Borrelia burgdorferi that binds host complement regulators factor H and FHL-1. Mol Microbiol 61:1220–1236PubMedCrossRef

Hellwage J, Meri T, Heikkila T, Alitalo A, Panelius J, Lahdenne P, Seppala I, Meri S (2001) The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem 276:8427–8435PubMedCrossRef

Hirschfeld M, Kirschning C, Schwandner R, Wesche H, Weis J, Wooten R, Weis J (1999) Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J. Immunol 163:2382–2386PubMed

Hovius J, Levi M, Fikrig E (2008) Salivating for knowledge: potential pharmacological agents in tick saliva. PLoS Med 5:e43PubMedCrossRef

Hubner A, Yang X, Nolen D, Popova T, Cabello F, Norgard M (2001) Expression of Borrelia burgdorferi OspC and DbpA is controlled by a RpoN-RpoS regulatory pathway. Proc Natl Acad Sci USA 98:12724–12729PubMedCrossRef

Hunfeld K, Ruzic-Sabljic E, Norris D, Kraiczy P, Strle F (2005) In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy. Antimicrob Agents Chemother 49:1294–1301PubMedCrossRef

Imai D, Barr B, Daft B, Bertone J, Feng S, Hodzic E, Johnston J, Olsen K, Barthold S (2011) Lyme neuroborreliosis in 2 horses. Vet Pathol 48:1151–1157PubMedCrossRef

Jin M, Kim S, Heo J, Lee M, Kim H, Paik S, Lee H, Lee J (2007) Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130:1071–1082PubMedCrossRef

Jones N, Germain A, Riley K, Bautista C, Taylor W, Wells A (1994) Borrelia burgdorferi decreases hyaluronan synthesis but increases IL-6 production by fibroblasts. Microb Pathog 16:261–267PubMedCrossRef

Kang J, Nan X, Jin M, Youn S, Ryu Y, Mah S, Han S, Lee H, Paik S, Lee J (2009) Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 31:873–884PubMedCrossRef

Kannian P, Drouin E, Glickstein L, Kwok W, Nepom G, Steere A (2007) Decline in the frequencies of Borrelia burgdorferi OspA161 175-specific T cells after antibiotic therapy in HLA-DRB1*0401-positive patients with antibiotic-responsive or antibiotic-refractory lyme arthritis. J. Immunol 179:6336–6342PubMed

Keller A, Graefen A, Ball M, Matzas M, Boisguerin V, Maixner F, Leidinger P, Backes C, Khairat R, Forster M, Stade B, Franke A, Mayer J, Spangler J, McLaughlin S, Shah M, Lee C, Harkins T, Sartori A, Moreno-Estrada A, Henn B, Sikora M, Semino O, Chiaroni J, Rootsi S, Myres N, Cabrera V, Underhill P, Bustamante C, Vigl E, Samadelli M, Cipollini G, Haas J, Katus H, O’Connor B, Carlson M, Meder B, Blin N, Meese E, Pusch C, Zink A (2012) New insights into the Tyrolean Iceman’s origin and phenotype as inferred by whole-genome sequencing. Nat. Commun. 3:698PubMedCrossRef

Kenedy MR, Lenhart TR, Akins DR (2012) The role of Borrelia burgdorferi outer surface proteins. FEMS Immunol Med Microbiol 66:1–19. doi:10.1111/j.1574-695X.2012.00980.x PubMedCrossRef

Klempner M, Noring R, Epstein M, McCloud B, Hu R, Limentani S, Rogers R (1995) Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis 171:1258–1265PubMedCrossRef

Kraiczy P, Hartmann K, Hellwage J, Skerka C, Kirschfink M, Brade V, Zipfel P, Wallich R, Stevenson B (2004) Immunological characterization of the complement regulator factor H-binding CRASP and Erp proteins of Borrelia burgdorferi. Int J Med Microbiol 293:152–157PubMed

Lam T, Nguyen T, Montgomery R, Kantor F, Fikrig E, Flavell R (1994) Outer surface proteins E and F of Borrelia burgdorferi, the agent of Lyme disease. Infect Immun 62:290–298PubMed

Lawrenz M, Wooten R, Zachary J, Drouin S, Weis J, Wetsel R, Norris S (2003) Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice. Infect Immun 71:4432–4440PubMedCrossRef

Li X, Pal U, Ramamoorthi N, Liu X, Desrosiers D, Eggers C, Anderson J, Radolf J, Fikrig E (2007) The Lyme disease agent Borrelia burgdorferi requires BB0690, a Dps homologue, to persist within ticks. Mol Microbiol 63:694–710PubMed

Liang F, Brown E, Wang T, Iozzo R, Fikrig E (2004) Protective niche for Borrelia burgdorferi to evade humoral immunity. Am J Pathol 165:977–985PubMedCrossRef

Lischer C, Leutenegger C, Braun U, Lutz H (2000) Diagnosis of Lyme disease in two cows by the detection of Borrelia burgdorferi DNA. Vet. Rec 146:497–499PubMedCrossRef

Littman M, Goldstein R, Labato M, Lappin M, Moore G (2006) ACVIM small animal consensus statement on Lyme disease in dogs: diagnosis, treatment, and prevention. J Vet Intern Med 20:422–434PubMedCrossRef

Ljostad U, Skogvoll E, Eikeland R, Midgard R, Skarpaas T, Berg A, Mygland A (2008) Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol 7:690–695PubMedCrossRef

Lockhart E, Green A, Flynn J (2006) IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol 177:4662–4669PubMed

Magnarelli L, Ijdo J, Van Andel A, Wu C, Padula S, Fikrig E (2000) Serologic confirmation of Ehrlichia equi and Borrelia burgdorferi infections in horses from the northeastern United States. J Am Vet Med Assoc 217:1045–1050PubMedCrossRef

Margos G, Vollmer S, Ogden N, Fish D (2011) Population genetics, taxonomy, phylogeny and evolution of Borrelia burgdorferi sensu lato. Infect. Genet. Evol 11:1545–1563PubMedCrossRef

Martin B, Hirota K, Cua D, Stockinger B, Veldhoen M (2009) Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31:321–330PubMedCrossRef

Miller J, Ma Y, Bian J, Sheehan K, Zachary J, Weis J, Schreiber R, Weis J (2008) A critical role for type I IFN in arthritis development following Borrelia burgdorferi infection of mice. J. Immunol 181:8492–8503PubMed

Moreira L, El Kasmi K, Smith A, Finkelstein D, Fillon S, Kim Y, Nunez G, Tuomanen E, Murray P (2008) The TLR2-MyD88-NOD2-RIPK2 signalling axis regulates a balanced pro-inflammatory and IL-10-mediated anti-inflammatory cytokine response to Gram-positive cell walls. Cell Microbiol 10:2067–2077PubMedCrossRef

Morgenstern K, Baljer G, Norris D, Kraiczy P, Hanssen-Hubner C, Hunfeld K (2009) In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease. Antimicrob Agents Chemother 53:1281–1284PubMedCrossRef

Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 17:8–16PubMedCrossRef

Ohnishi J, Piesman J, de Silva A (2001) Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc Natl Acad Sci USA 98:670–675PubMedCrossRef

Omueti K, Beyer J, Johnson C, Lyle E, Tapping R (2005) Domain exchange between human toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination. J Biol Chem 280:36616–36625PubMedCrossRef

Oosting M, Berende A, Sturm P, Ter Hofstede H, de Jong D, Kanneganti T, van der Meer J, Kullberg B, Netea M, Joosten L (2010) Recognition of Borrelia burgdorferi by NOD2 is central for the induction of an inflammatory reaction. J Infect Dis 201:1849–1858PubMedCrossRef

Pal U, de Silva A, Montgomery R, Fish D, Anguita J, Anderson J, Lobet Y, Fikrig E (2000) Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J. Clin. Invest. 106:561–569PubMedCrossRef

Pal U, Yang X, Chen M, Bockenstedt L, Anderson J, Flavell R, Norgard M, Fikrig E (2004) OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J. Clin. Invest. 113:220–230PubMed

Pasare C, Medzhitov R (2004) Toll-like receptors: linking innate and adaptive immunity. Microbes Infect 6:1382–1387PubMedCrossRef

Paul J, Karmakar S, De T (2012) TLR mediated distinct IFN-gamma/IL-10 pattern induces protective immunity against murine visceral leishmaniasis. Eur J Immunol 23:201242428

Petzke M, Brooks A, Krupna M, Mordue D, Schwartz I (2009) Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells. J. Immunol. 183:5279–5292PubMedCrossRef

Poland G (2011) Vaccines against Lyme disease: what happened and what lessons can we learn? Clin Infect Dis 52:s253–s258PubMedCrossRef

Priest H, Irby N, Schlafer D, Divers T, Wagner B, Glaser A, Chang Y, Smith M (2012) Diagnosis of Borrelia-associated uveitis in two horses. Vet Ophthalmol 23:1463–5224

Probert W, Johnson B (1998) Identification of a 47 kDa fibronectin-binding protein expressed by Borrelia burgdorferi isolate B31. Mol Microbiol 30:1003–1015PubMedCrossRef

Radolf J, Caimano M, Stevenson B, Hu L (2012) Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol 10:87–99PubMed

Ramamoorthi N, Narasimhan S, Pal U, Bao F, Yang X, Fish D, Anguita J, Norgard M, Kantor F, Anderson J, Koski R, Fikrig E (2005) The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature 436:573–577PubMedCrossRef

Rana A, Minz RW, Aggarwal R, Anand S, Pasricha N, Singh S (2012) Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus. Lupus 21:1105–1112PubMedCrossRef

Rose C, Fawcett P, Gibney K (2001) Arthritis following recombinant outer surface protein A vaccination for Lyme disease. J Rheumatol 28:2555–2557PubMed

Samuels D (2011) Gene regulation in Borrelia burgdorferi. Annu Rev Microbiol 65:479–499PubMedCrossRef

Schroder N, Diterich I, Zinke A, Eckert J, Draing C, von Baehr V, Hassler D, Priem S, Hahn K, Michelsen K, Hartung T, Burmester G, Gobel U, Hermann C, Schumann R (2005) Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J. Immunol. 175:2534–2540PubMed

Schuijt T, Coumou J, Narasimhan S, Dai J, Deponte K, Wouters D, Brouwer M, Oei A, Roelofs J, van Dam A, van der Poll T, Van’t Veer C, Hovius J, Fikrig E (2011) A tick mannose-binding lectin inhibitor interferes with the vertebrate complement cascade to enhance transmission of the Lyme disease agent. Cell Host Microbe 10:136–146PubMedCrossRef

Schwan T, Piesman J, Golde W, Dolan M, Rosa P (1995) Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci USA 92:2909–2913PubMedCrossRef

Shaw S, Binns S, Birtles R, Day M, Smithson R, Kenny M (2005) Molecular evidence of tick-transmitted infections in dogs and cats in the United Kingdom. Vet. Rec. 157:645–648PubMed

Shi C, Sahay B, Russell J, Fortner K, Hardin N, Sellati T, Budd R (2011) Reduced immune response to Borrelia burgdorferi in the absence of gammadelta T cells. Infect Immun 79:3940–3946PubMedCrossRef

Sonderegger F, Ma Y, Maylor-Hagan H, Brewster J, Huang X, Spangrude G, Zachary J, Weis J, Weis J (2012) Localized production of IL-10 suppresses early inflammatory cell infiltration and subsequent development of IFN-gamma-mediated Lyme arthritis. J. Immunol. 188:1381–1393PubMedCrossRef

Stanek G, Wormser G, Gray J, Strle F (2012) Lyme borreliosis. Lancet 379:461–473PubMedCrossRef

Stanneck D, Rass J, Radeloff I, Kruedewagen E, Le Sueur C, Hellmann K, Krieger K (2012) Evaluation of the long-term efficacy and safety of an imidacloprid 10 %/flumethrin 4.5 % polymer matrix collar (Seresto(R)) in dogs and cats naturally infested with fleas and/or ticks in multicentre clinical field studies in Europe. Parasit. Vectors. 5:66PubMedCrossRef

Steere A, Angelis S (2006) Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum 54:3079–3086PubMedCrossRef

Steere A, Malawista S, Snydman D, Shope R, Andiman W, Ross M, Steele F (1977) Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. Arthritis Rheum 20:7–17PubMedCrossRef

Steere A, Sikand V, Meurice F, Parenti D, Fikrig E, Schoen R, Nowakowski J, Schmid C, Laukamp S, Buscarino C, Krause D (1998) Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med 339:209–215PubMedCrossRef

Steere A, Klitz W, Drouin E, Falk B, Kwok W, Nepom G, Baxter-Lowe L (2006) Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide. J Exp Med 203:961–971PubMedCrossRef

Stevenson B, Schwan T, Rosa P (1995) Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun 63:4535–4539PubMed

Straubinger R, Summers B, Chang Y, Appel M (1997) Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol 35:111–116PubMed

Straubinger R, Straubinger A, Summers B, Jacobson R, Erb H (1998) Clinical manifestations, pathogenesis, and effect of antibiotic treatment on Lyme borreliosis in dogs. Wien Klin Wochenschr 110:874–881PubMed

Strle K, Shin J, Glickstein L, Steere A (2012) Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis. Arthritis Rheum 64:1497–1507PubMedCrossRef

Szczepanski A, Furie M, Benach J, Lane B, Fleit H (1990) Interaction between Borrelia burgdorferi and endothelium in vitro. J. Clin. Invest. 85:1637–1647PubMedCrossRef

Taylor M (2001) Recent developments in ectoparasiticides. Vet. J. 161:253–268PubMedCrossRef

Trollmo C, Meyer A, Steere A, Hafler D, Huber B (2001) Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1 alpha L is a partial agonist for outer surface protein A-reactive T cells. J. Immunol. 166:5286–5291PubMed

Urban E, Chapoval A, Pauza C (2010) Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells. Clin. Dev. Immunol. 2010:732893PubMedCrossRef

van Burgel N, Balmus N, Fikrig E, van Dam A (2011) Infectivity of Borrelia burgdorferi sensu lato is unaltered in C3-deficient mice. Ticks Tick Borne Dis. 2:20–26PubMedCrossRef

Vijverberg H, van der Zalm J, van der Bercken J (1982) Similar mode of action of pyrethroids and DDT on sodium channel gating in myelinated nerves. Nature 295:601–603PubMedCrossRef

Wesch D, Peters C, Oberg H, Pietschmann K, Kabelitz D (2011) Modulation of gammadelta T cell responses by TLR ligands. Cell Mol Life Sci 68:2357–2370PubMedCrossRef

Wong CK, Lit LC, Tam LS, Li EK, Wong PT, Lam CW (2008) Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin. Immunol. 127:385–393PubMedCrossRef

Wooten R, Ma Y, Yoder R, Brown J, Weis J, Zachary J, Kirschning C, Weis J (2002) Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J. Immunol. 168:348–355PubMed

Wormser G, Dattwyler R, Shapiro E, Halperin J, Steere A, Klempner M, Krause P, Bakken J, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler J, Nadelman R (2006) The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43:1089–1134PubMedCrossRef

Yang X, Pal U, Alani S, Fikrig E, Norgard M (2004) Essential role for OspA/B in the life cycle of the Lyme disease spirochete. J Exp Med 199:641–648PubMedCrossRef

Zhang J, Norris S (1998a) Genetic variation of the Borrelia burgdorferi gene vlsE involves cassette-specific, segmental gene conversion. Infect Immun 66:3698–3704PubMed

Zhang J, Norris S (1998b) Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi. Infect Immun 66:3689–3697PubMed

Zhang J, Hardham J, Barbour A, Norris S (1997) Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89:275–285PubMedCrossRef

Titel: Lyme disease: aetiopathogenesis, factors for disease development and control
verfasst von: I. R. Kean
K. L. Irvine
Publikationsdatum: 01.04.2013
Verlag: SP Birkhäuser Verlag Basel
Erschienen in: Inflammopharmacology / Ausgabe 2/2013
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-012-0156-2

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Lyme disease: aetiopathogenesis, factors for disease development and control

Abstract

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2013

Antihypernociceptive activity of anethole in experimental inflammatory pain

Gemfibrozil and its combination with metformin on pleiotropic effect on IL-10 and adiponectin and anti-atherogenic treatment in insulin resistant type 2 diabetes mellitus rats

Immunosuppressive effects of Euphorbia hirta in experimental animals

Frans P. Nijkamp, Michael J. Parnham (eds): Principles of immunopharmacology, 3rd revised and extended edition

Do anti-TNF-α drugs increase cancer risk in rheumatoid arthritis patients?

The pharmacological modulation of allergen-induced asthma